|
|
||||||||
1 Graduate School of Pharmaceutical Sciences, University of Tokyo, Hongo, Bunkyo-ku, Tokyo 113-0033, Japan; 2 Department of Experimental Pediatrics, University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030; 3 Division of Clinical Pharmacology and Toxicology, Department of Medicine, University Hospital, CH-8091 Zurich, Switzerland; 4 Faculty of Pharmaceutical Sciences, Setsunan University, Nagao-toge-machi, Hirakata, 573-01, Japan; and 5 Core Research for Evolutional Sciences and Technology, Japan Science and Technology, Tokyo 113-0033, Japan
We found previously that expression of multidrug
resistance-associated protein (MRP) 3 is induced in a mutant rat strain
(Eisai hyperbilirubinemic rats) whose canalicular multispecific organic anion transporter (cMOAT/MRP2) function is hereditarily defective and
in normal Sprague-Dawley (SD) rats after ligation of the common bile
duct. In the present study, the inducible nature of MRP3 was examined, using Northern and Western blot analyses, in comparison with that of other secondary active [Na+-taurocholic
acid cotransporting polypeptide (Ntcp), organic anion transporting
polypeptide 1 (oatp1), and organic cation transporter (OCT1)] and
primary active [P-glycoprotein (P-gp), cMOAT/MRP2, and
MRP6] transporters.
-Naphthylisothiocyanate treatment and common bile duct ligation induced expression of P-gp and MRP3, whereas
expression of Ntcp, oatp1, and OCT1 was reduced by the same treatment.
Although expression of MRP3 was also induced by administration of
phenobarbital, that of cMOAT/MRP2, MRP1, and MRP6 was not affected by
any of these treatments. Moreover, the mRNA level of MRP3, but not that
of P-gp, was increased in SD rats after administration of bilirubin and
in Gunn rats whose hepatic bilirubin concentration is elevated because
of a defect in the expression of UDP-glucuronosyl transferase. However,
the MRP3 protein level was not affected by bilirubin administration. Although the increased MRP3 mRNA level was associated with the increased concentration of bilirubin and/or its glucuronides in mutant
rats and in SD rats that had undergone common bile duct ligation or
-naphthylisothiocyanate treatment, we must assume that factor(s)
other than these physiological substances are also involved in the
increased protein level of MRP3.
induction; multidrug resistance-associated protein; canalicular multispecific organic anion transporter; cholestasis; bilirubin glucuronide
This article has been cited by other articles:
![]() |
S. S. M. Villanueva, M. L. Ruiz, C. I. Ghanem, M. G. Luquita, V. A. Catania, and A. D. Mottino Hepatic Synthesis and Urinary Elimination of Acetaminophen Glucuronide Are Exacerbated in Bile Duct-Ligated Rats Drug Metab. Dispos., March 1, 2008; 36(3): 475 - 480. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Leslie, G. Ghibellini, K.-i. Nezasa, and K. L.R. Brouwer Biotransformation and transport of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in bile duct-cannulated wild-type and Mrp2/Abcc2-deficient (TR ) Wistar rats Carcinogenesis, December 1, 2007; 28(12): 2650 - 2656. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Okada, J. Shoda, M. Kano, S. Suzuki, N. Ohtake, M. Yamamoto, H. Takahashi, H. Utsunomiya, K. Oda, K. Sato, et al. Inchinkoto, a herbal medicine, and its ingredients dually exert Mrp2/MRP2-mediated choleresis and Nrf2-mediated antioxidative action in rat livers Am J Physiol Gastrointest Liver Physiol, May 1, 2007; 292(5): G1450 - G1463. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Chen, S.-Y. Cai, S. Xu, L. A. Denson, C. J. Soroka, and J. L. Boyer Nuclear receptors RXR{alpha}:RAR{alpha} are repressors for human MRP3 expression Am J Physiol Gastrointest Liver Physiol, May 1, 2007; 292(5): G1221 - G1227. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nishiya, H. Kataoka, K. Mori, M. Goto, T. Sugawara, and K. Furuhama Tienilic Acid Enhances Hyperbilirubinemia in Eisai Hyperbilirubinuria Rats through Hepatic Multidrug Resistance-Associated Protein 3 and Heme Oxygenase-1 Induction Toxicol. Sci., June 1, 2006; 91(2): 651 - 659. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Geier, C. G. Dietrich, S. Voigt, M. Ananthanarayanan, F. Lammert, A. Schmitz, M. Trauner, H. E. Wasmuth, D. Boraschi, N. Balasubramaniyan, et al. Cytokine-dependent regulation of hepatic organic anion transporter gene transactivators in mouse liver Am J Physiol Gastrointest Liver Physiol, November 1, 2005; 289(5): G831 - G841. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Chandra, P. Zhang, and K. L. R. Brouwer Short-term regulation of multidrug resistance-associated protein 3 in rat and human hepatocytes Am J Physiol Gastrointest Liver Physiol, June 1, 2005; 288(6): G1252 - G1258. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. V. St-Pierre, T. Stallmach, A. Freimoser Grundschober, J.-F. Dufour, M. A. Serrano, J. J. G. Marin, Y. Sugiyama, and P. J. Meier Temporal expression profiles of organic anion transport proteins in placenta and fetal liver of the rat Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2004; 287(6): R1505 - R1516. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Z. Turncliff, P. J. Meier, and K. L. R. Brouwer EFFECT OF DEXAMETHASONE TREATMENT ON THE EXPRESSION AND FUNCTION OF TRANSPORT PROTEINS IN SANDWICH-CULTURED RAT HEPATOCYTES Drug Metab. Dispos., August 1, 2004; 32(8): 834 - 839. [Abstract] [Full Text] [PDF] |
||||
![]() |
J E Ros, T A D Roskams, M Geuken, R Havinga, P L Splinter, B E Petersen, N F LaRusso, D M van der Kolk, F Kuipers, K N Faber, et al. ATP binding cassette transporter gene expression in rat liver progenitor cells Gut, July 1, 2003; 52(7): 1060 - 1067. [Abstract] [Full Text] |
||||
![]() |
S. Wang, D. P. Hartley, S. L. Ciccotto, S. H. Vincent, R. B. Franklin, and M.-S. Kim INDUCTION OF HEPATIC PHASE II DRUG-METABOLIZING ENZYMES BY 1,7-PHENANTHROLINE IN RATS IS ACCOMPANIED BY INDUCTION OF MRP3 Drug Metab. Dispos., June 1, 2003; 31(6): 773 - 775. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Trauner and J. L. Boyer Bile Salt Transporters: Molecular Characterization, Function, and Regulation Physiol Rev, April 1, 2003; 83(2): 633 - 671. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hitzl, K. Klein, U. M. Zanger, P. Fritz, A. K. Nussler, P. Neuhaus, and M. F. Fromm Influence of Omeprazole on Multidrug Resistance Protein 3 Expression in Human Liver J. Pharmacol. Exp. Ther., February 1, 2003; 304(2): 524 - 530. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Oleschuk, R. G. Deeley, and S. P. C. Cole Substitution of Trp1242 of TM17 alters substrate specificity of human multidrug resistance protein 3 Am J Physiol Gastrointest Liver Physiol, February 1, 2003; 284(2): G280 - G289. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Cao, B. Stieger, P. J. Meier, and M. Vore Expression of rat hepatic multidrug resistance-associated proteins and organic anion transporters in pregnancy Am J Physiol Gastrointest Liver Physiol, September 1, 2002; 283(3): G757 - G766. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Gerk and M. Vore Regulation of Expression of the Multidrug Resistance-Associated Protein 2 (MRP2) and Its Role in Drug Disposition J. Pharmacol. Exp. Ther., August 1, 2002; 302(2): 407 - 415. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Johnson and C. D. Klaassen Regulation of Rat Multidrug Resistance Protein 2 by Classes of Prototypical Microsomal Enzyme Inducers That Activate Distinct Transcription Pathways Toxicol. Sci., June 1, 2002; 67(2): 182 - 189. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Gotoh, Y. Kato, B. Stieger, P. J. Meier, and Y. Sugiyama Gender difference in the Oatp1-mediated tubular reabsorption of estradiol 17beta -D-glucuronide in rats Am J Physiol Endocrinol Metab, June 1, 2002; 282(6): E1245 - E1254. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Tanaka, Y. Kobayashi, E. C. Gabazza, K. Higuchi, T. Kamisako, M. Kuroda, K. Takeuchi, M. Iwasa, M. Kaito, and Y. Adachi Increased renal expression of bilirubin glucuronide transporters in a rat model of obstructive jaundice Am J Physiol Gastrointest Liver Physiol, April 1, 2002; 282(4): G656 - G662. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Rost, S. Mahner, Y. Sugiyama, and W. Stremmel Expression and localization of the multidrug resistance-associated protein 3 in rat small and large intestine Am J Physiol Gastrointest Liver Physiol, April 1, 2002; 282(4): G720 - G726. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. J. Cherrington, D. P. Hartley, N. Li, D. R. Johnson, and C. D. Klaassen Organ Distribution of Multidrug Resistance Proteins 1, 2, and 3 (Mrp1, 2, and 3) mRNA and Hepatic Induction of Mrp3 by Constitutive Androstane Receptor Activators in Rats J. Pharmacol. Exp. Ther., January 1, 2002; 300(1): 97 - 104. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. Guo, S. Choudhuri, and C. D. Klaassen Induction Profile of Rat Organic Anion Transporting Polypeptide 2 (oatp2) by Prototypical Drug-Metabolizing Enzyme Inducers That Activate Gene Expression through Ligand-Activated Transcription Factor Pathways J. Pharmacol. Exp. Ther., January 1, 2002; 300(1): 206 - 212. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. E. Kostrubsky, M. Vore, E. Kindt, J. Burliegh, K. Rogers, G. Peter, D. Altrogge, and M. W. Sinz The Effect of Troglitazone Biliary Excretion on Metabolite Distribution and Cholestasis in Transporter-Deficient Rats Drug Metab. Dispos., December 1, 2001; 29(12): 1561 - 1566. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Morita, H. Kusuhara, T. Sekine, H. Endou, and Y. Sugiyama Functional Characterization of Rat Organic Anion Transporter 2 in LLC-PK1 Cells J. Pharmacol. Exp. Ther., September 1, 2001; 298(3): 1179 - 1184. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Xiong, K. C. Turner, E. S. Ward, P. L. M. Jansen, and K. L. R. Brouwer Altered Hepatobiliary Disposition of Acetaminophen Glucuronide in Isolated Perfused Livers from Multidrug Resistance-Associated Protein 2-Deficient TR- Rats J. Pharmacol. Exp. Ther., November 1, 2000; 295(2): 512 - 518. [Abstract] [Full Text] |
||||
![]() |
E. M. Leslie, K.-i. Ito, P. Upadhyaya, S. S. Hecht, R. G. Deeley, and S. P. C. Cole Transport of the beta -O-Glucuronide Conjugate of the Tobacco-specific Carcinogen 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) by the Multidrug Resistance Protein 1 (MRP1). REQUIREMENT FOR GLUTATHIONE OR A NON-SULFUR-CONTAINING ANALOG J. Biol. Chem., July 20, 2001; 276(30): 27846 - 27854. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |